Niacinamide insulin aspart, human 100 UNT/ML Injectable Solution
RxNorm concept 2730174, clinical drug (scd). Prescribable name: insulin aspart (niacinamide) 100 UNT/ML Injectable Solution.
- RxCUI
- 2730174
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2730174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
insulin analog, aspart (niacinamide) 100 UNT/ML Injectable Solution
Related concepts
- insulin aspart, human 100 UNT/ML (SCDC, consists of)
- Injectable Solution (DF, has dose form)
- Niacinamide insulin aspart, human 100 UNT/ML Injectable Solution [Fiasp] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2730174 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2730174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2730174. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.